EUVIMEDEUVIMED entdecken
Open Access

Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18 F-FET PET

Johannes Lohmeier, Helena Radbruch, Winfried Brenner, Bernd Hamm, Anna Tietze, Marcus R Makowski

Journal of Nuclear Medicine · 2023-11 · 64 (11) · 1683-1689

DOI: 10.2967/jnumed.123.265642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 31.08.2023. Verfasst von Johannes Lohmeier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany; johannes.lohmeier@charite.de. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular markers are of increasing importance for classifying, treating, and determining the prognosis for central nervous system tumors. Isocitrate dehydrogenase (IDH) is a critical regulator of glucose and amino acid metabolism. Our objective was to investigate metabolic reprogramming of glioma using compartmental uptake (CU) characteristics in O-(2-18F-fluoroethyl)-l-tyrosine (FET) PET and to evaluate its diagnostic potential for IDH genotyping.

Methods

Between 2017 and 2022, patients with confirmed glioma were preoperatively investigated using static 18F-FET PET. Metabolic tumor volume (MTV), MTV for 60%-100% uptake (MTV60), and T2-weighted and contrast-enhancing lesion volumes were automatically segmented using U-Net neural architecture and isocontouring. Volume intersections were determined using the Dice coefficient. Uptake characteristics were determined for metabolically defined compartments (central [80%-100%] and peripheral [60%-75%] areas of 18F-FET uptake). CU ratio was defined as the fraction between the peripheral and central compartments. Mean target-to-background ratio was calculated. Comparisons were performed using parametric and nonparametric tests. Receiver-operating-characteristic curves, regression, and correlation were used for statistical analysis.

Results

In total, 52 participants (male, 27, female, 25; mean age ± SD, 51 ± 16 y) were evaluated. MTV60 was greater and distinct from contrast-enhancing lesion volume (P = 0.046). IDH-mutated tumors presented a greater volumetric CU ratio and SUV CU ratio than IDH wild-type tumors (P 0.05). SUV CU ratio (AUC, 0.72; P = 0.005) and target-to-background ratio (AUC, 0.68; P = 0.016) achieved modest diagnostic performance-inferior to the volumetric CU ratio. Furthermore, the classification of loss of heterozygosity of chromosomes 1p and 19q (AUC, 0.75; P = 0.019), MGMT promoter methylation (AUC, 0.70; P = 0.011), and ATRX loss (AUC, 0.73; P = 0.004) by amino acid PET was evaluated.

Conclusion

We proposed parametric 18F-FET PET as a noninvasive metabolic biomarker for the evaluation of CU characteristics, which differentiated IDH genotype with excellent diagnostic performance, establishing a critical association between spatial metabolic heterogeneity, mitochondrial tricarboxylic acid cycle, and genomic features with critical implications for clinical management and the diagnostic workup of patients with central nervous system cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaHumansMaleFemaleIsocitrate DehydrogenaseGenotypePositron-Emission TomographyTyrosineAmino AcidsMagnetic Resonance Imaging

Stichwörter der Autor:innen

18F-FET PET/MRIIDH genotypingamino acid metabolismbiomarkerspatial metabolic heterogeneity

Substanzen

Isocitrate DehydrogenaseTyrosineAmino Acids

Autor:innen und Institutionen

  • Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany; johannes.lohmeier@charite.de.
  • Department of Neuropathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Institute of Neuroradiology, Charité-Universitätsmedizin Berlin, Berlin, Germany; and.
  • Department of Radiology, Technical University Munich, Munich, Germany.

Zitieren

APA

Lohmeier, J., Radbruch, H., Brenner, W., Hamm, B., Tietze, A., & Makowski, M. R. (2023). Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18 F-FET PET. Journal of Nuclear Medicine, 64(11), 1683-1689. https://doi.org/10.2967/jnumed.123.265642

Vancouver

Lohmeier J, Radbruch H, Brenner W, Hamm B, Tietze A, Makowski MR. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18 F-FET PET. Journal of Nuclear Medicine. 2023;64(11):1683-1689. doi:10.2967/jnumed.123.265642

BibTeX
@article{Lohmeier2023,
  author = {Lohmeier, Johannes and Radbruch, Helena and Brenner, Winfried and Hamm, Bernd and Tietze, Anna and Makowski, Marcus R},
  title = {Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18 F-FET PET},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  volume = {64},
  number = {11},
  pages = {1683--1689},
  doi = {10.2967/jnumed.123.265642}
}
Kostenlos starten →